Biofrontera (NASDAQ:BFRI) Trading Down 1.7% – Here’s What Happened

Biofrontera Inc. (NASDAQ:BFRI) traded down 1.7% on Wednesday . The stock traded as low as $0.68 and last traded at $0.70. 28,927 shares traded hands during mid-day trading, a decline of 97% from the average session volume of 915,523 shares. The stock had previously closed at $0.71.

Biofrontera Trading Down 1.7 %

The stock has a 50 day moving average of $0.83 and a 200-day moving average of $0.96. The stock has a market capitalization of $6.62 million, a P/E ratio of -0.31 and a beta of 0.37.

Institutional Trading of Biofrontera

Several institutional investors and hedge funds have recently made changes to their positions in BFRI. Rosalind Advisors Inc. grew its holdings in shares of Biofrontera by 63.9% in the fourth quarter. Rosalind Advisors Inc. now owns 811,918 shares of the company’s stock worth $885,000 after purchasing an additional 316,428 shares during the last quarter. AIGH Capital Management LLC boosted its position in Biofrontera by 61.8% in the 4th quarter. AIGH Capital Management LLC now owns 811,097 shares of the company’s stock valued at $884,000 after buying an additional 309,663 shares during the period. Finally, Virtu Financial LLC bought a new position in Biofrontera in the 4th quarter worth about $48,000. 10.08% of the stock is currently owned by institutional investors.

About Biofrontera

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.